GE Healthcare to Acquire Intelerad for $2.3 Billion to Strengthen AI and Cloud-Based Medical Imaging Capabilities

Intelligent Finance APP learned that GE Healthcare Technologies (GEHC.US) will acquire Intelerad Medical Systems Inc., a medical imaging software manufacturer, for $2.3 billion in cash, to expand its layout in the fields of cloud software and artificial intelligence.

GE Healthcare's stock price saw little change in after-hours trading in New York following the announcement of the deal. The stock has fallen 4.4% year-to-date as of Thursday's close.

As enterprises leverage artificial intelligence to assist in interpreting scans, the medical imaging industry is undergoing a transformation. Intelerad's software is applied in radiology and cardiology, playing a significant role in the outpatient field — GE Healthcare stated that this will complement the company’s presence in the hospital sector. The majority of Intelerad's revenue comes from recurring subscription services, with annual revenue growth at a rate of over ten percent.

GE Healthcare stated that Intelerad is expected to generate revenue of approximately US$270 million in its first full fiscal year after the acquisition. This transaction will effectively drive robust growth in the group's total revenue and adjusted earnings before interest and taxes (EBIT). It should be noted that, after taking into account relevant financing arrangements, the adjusted profit may face a "slight dilution" impact in the short term. However, this impact is expected to be significantly mitigated through the implementation of systematic cost reduction measures. The above financial forecasts and strategic arrangements have been confirmed through the company’s official disclosure procedures.

GE Healthcare, which was spun off from General Electric in 2023, specializes in medical imaging and patient monitoring equipment. According to available data, this is the company’s largest acquisition since becoming independent. Intelerad Medical Systems, a private company founded in Montreal in 1999, operates in both the United States and Canada.

The transaction will be funded by existing cash and debt financing proceeds, with closing expected in the first half of 2026.

Evercore served as the financial advisor to GE Healthcare, and Sidley Austin LLP served as the transaction legal counsel. UBS Investment Bank served as the financial advisor to Intelerad, and Skadden, Arps, Slate, Meagher & Flom LLP served as the transaction legal counsel.